BBR Partners LLC Invests $216,000 in Agilent Technologies, Inc. (NYSE:A)

BBR Partners LLC acquired a new stake in Agilent Technologies, Inc. (NYSE:A) during the third quarter, Holdings Channel reports. The institutional investor acquired 1,456 shares of the medical research company’s stock, valued at approximately $216,000.

Other institutional investors have also made changes to their positions in the company. Crewe Advisors LLC grew its stake in Agilent Technologies by 114.8% in the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 101 shares in the last quarter. Livelsberger Financial Advisory bought a new position in shares of Agilent Technologies in the third quarter valued at $28,000. Ridgewood Investments LLC acquired a new position in Agilent Technologies during the second quarter worth $29,000. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies during the third quarter worth $31,000. Finally, Fortitude Family Office LLC lifted its stake in Agilent Technologies by 68.3% in the third quarter. Fortitude Family Office LLC now owns 234 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 95 shares during the last quarter. Institutional investors own 87.42% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. StockNews.com lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Tuesday. UBS Group upped their price objective on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research note on Thursday, August 22nd. Evercore ISI lifted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. Stifel Nicolaus restated a “buy” rating and issued a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. Finally, TD Cowen lifted their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, Agilent Technologies has an average rating of “Hold” and an average target price of $143.40.

Insider Activity

In related news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now directly owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Stock Up 2.8 %

Shares of A opened at $138.11 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. The stock has a market capitalization of $39.68 billion, a PE ratio of 28.65, a P/E/G ratio of 5.91 and a beta of 1.07. The firm’s 50 day moving average is $137.72 and its 200-day moving average is $137.43. Agilent Technologies, Inc. has a 12 month low of $124.10 and a 12 month high of $155.35.

Agilent Technologies Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be issued a $0.248 dividend. The ex-dividend date is Tuesday, December 31st. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. This represents a $0.99 annualized dividend and a yield of 0.72%. Agilent Technologies’s payout ratio is currently 20.54%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.